Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Financial Statements

1 Followers

Shanghai Haohai Biological Technology Co., Ltd. Class H Financial Overview

Shanghai Haohai Biological Technology Co., Ltd. Class H's market cap is currently HK$9.44B. The company's EPS TTM is HK$-0.26; its P/E ratio is 20.83; and it has a dividend yield of 4.28%. Shanghai Haohai Biological Technology Co., Ltd. Class H is scheduled to report earnings on March 20, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 2.40B	¥ 2.68B	¥ 2.63B	¥ 2.10B	¥ 1.75B
Gross Profit	¥ 1.56B	¥ 1.87B	¥ 1.85B	¥ 1.45B	¥ 1.26B
Operating Income	¥ 278.96M	¥ 347.93M	¥ 438.38M	¥ 155.81M	¥ 176.03M
EBITDA	¥ 480.36M	¥ 549.05M	¥ 713.41M	¥ 447.55M	¥ 550.45M
Net Income	¥ 244.51M	¥ 420.45M	¥ 416.12M	¥ 180.47M	¥ 352.23M
Balance Sheet
Cash & Short-Term Investments	¥ 2.52B	¥ 2.76B	¥ 2.75B	¥ 2.56B	¥ 2.91B
Total Assets	¥ 6.72B	¥ 7.12B	¥ 7.11B	¥ 6.89B	¥ 6.95B
Total Debt	¥ 398.67M	¥ 448.43M	¥ 407.95M	¥ 118.26M	¥ 105.51M
Net Debt	¥ -2.05B	¥ -2.18B	¥ -2.33B	¥ -2.42B	¥ -2.80B
Total Liabilities	¥ 1.12B	¥ 1.20B	¥ 1.09B	¥ 990.02M	¥ 890.07M
Stockholders' Equity	¥ 5.42B	¥ 5.58B	¥ 5.65B	¥ 5.51B	¥ 5.71B
Cash Flow
Free Cash Flow	¥ 446.40M	¥ 283.08M	¥ 367.22M	¥ -85.85M	¥ 70.19M
Operating Cash Flow	¥ 628.50M	¥ 648.57M	¥ 634.45M	¥ 231.30M	¥ 342.29M
Investing Cash Flow	¥ -10.81M	¥ 282.28M	¥ -376.65M	¥ -681.82M	¥ -148.09M
Financing Cash Flow	¥ -509.70M	¥ -390.35M	¥ -257.73M	¥ -288.35M	¥ -231.25M

Currency in CNY

Shanghai Haohai Biological Technology Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Shanghai Haohai Biological Technology Co., Ltd. Class H Debt to Assets

Balance Sheet >

Shanghai Haohai Biological Technology Co., Ltd. Class H Cash Flow

Cash Flow >

Shanghai Haohai Biological Technology Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >